No Data
Huapont Life Sciences (002004.SZ) subsidiary obtained the Pharmaceutical registration certificate for calcipotriene betamethasone ointment.
Huapont Life Sciences (002004.SZ) announced that its wholly-owned subsidiary Chongqing Huapont Pharmaceutical Co., Ltd. (hereinafter referred to as...)
Huapont Life Sciences (002004.SZ): The non-public issuance of exchangeable CSI Enterprise bonds has received a no-objection letter from the Shenzhen Stock Exchange.
Huapont Life Sciences (002004.SZ) announced that the company recently received a notice from the Shenzhen Stock Exchange (hereinafter referred to as "Shenzhen Exchange...").
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Huapont Life SciencesLtd (SZSE:002004) Stock Falls 8.2% in Past Week as Three-year Earnings and Shareholder Returns Continue Downward Trend
Huabang Health: 2024 Annual Results Forecast
Be Wary Of Huapont Life SciencesLtd (SZSE:002004) And Its Returns On Capital
Returns At Huapont Life SciencesLtd (SZSE:002004) Appear To Be Weighed Down